98 related articles for article (PubMed ID: 22975812)
1. [Molecular mechanisms underlying leukemic transformation of myelodysplastic syndromes (MDS) and chronic myelogenous leukemia (CML)].
Kitamura T; Watanabe-Okochi N; Inoue D; Togami K; Uchida T; Kagiyama Y; Kawabata K; Chiba S; Harada Y; Harada H; Kitaura J; Nakahara F
Rinsho Ketsueki; 2012 Aug; 53(8):734-9. PubMed ID: 22975812
[No Abstract] [Full Text] [Related]
2. Hes1 immortalizes committed progenitors and plays a role in blast crisis transition of chronic myelogenous leukemia.
Nakahara F
Rinsho Ketsueki; 2011 Jun; 52(6):329-41. PubMed ID: 21737984
[No Abstract] [Full Text] [Related]
3. Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells.
Nakahara F; Kitaura J; Uchida T; Nishida C; Togami K; Inoue D; Matsukawa T; Kagiyama Y; Enomoto Y; Kawabata KC; Chen-Yi L; Komeno Y; Izawa K; Oki T; Nagae G; Harada Y; Harada H; Otsu M; Aburatani H; Heissig B; Hattori K; Kitamura T
Blood; 2014 Jun; 123(25):3932-42. PubMed ID: 24825862
[TBL] [Abstract][Full Text] [Related]
4. Hes1 immortalizes committed progenitors and plays a role in blast crisis transition in chronic myelogenous leukemia.
Nakahara F; Sakata-Yanagimoto M; Komeno Y; Kato N; Uchida T; Haraguchi K; Kumano K; Harada Y; Harada H; Kitaura J; Ogawa S; Kurokawa M; Kitamura T; Chiba S
Blood; 2010 Apr; 115(14):2872-81. PubMed ID: 19861684
[TBL] [Abstract][Full Text] [Related]
5. A case of myelodysplastic syndrome developed blastic crisis of chronic myelogenous leukemia with acquisition of major BCR/ABL.
Onozawa M; Fukuhara T; Takahata M; Yamamoto Y; Miyake T; Maekawa I
Ann Hematol; 2003 Sep; 82(9):593-5. PubMed ID: 12898186
[TBL] [Abstract][Full Text] [Related]
6. High expression of interleukin-2 receptor α-chain (CD25) in myelodysplastic syndrome preceding acute myeloid leukemia and chronic myeloid leukemia in myeloid blast crisis.
Nakase K; Kita K; Kyo T; Katayama N
Leuk Lymphoma; 2017 May; 58(5):1268-1270. PubMed ID: 27736287
[No Abstract] [Full Text] [Related]
7. Chromosome abnormalities in hematopoietic malignancies.
Kamada N
Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1332-8. PubMed ID: 3073610
[No Abstract] [Full Text] [Related]
8. A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases.
Grossmann V; Kohlmann A; Zenger M; Schindela S; Eder C; Weissmann S; Schnittger S; Kern W; Müller MC; Hochhaus A; Haferlach T; Haferlach C
Leukemia; 2011 Mar; 25(3):557-60. PubMed ID: 21274004
[No Abstract] [Full Text] [Related]
9. Coexistence of independent myelodysplastic and Philadelphia chromosome positive clones in a patient treated with hydroxyurea.
Flamm MJ; Murty VV; Rao PH; Nichols GL
Leuk Res; 2002 Apr; 26(4):417-20. PubMed ID: 11839390
[TBL] [Abstract][Full Text] [Related]
10. Absence of gene mutation in TRAIL receptor 1 (TRAIL-R1) and TRAIL receptor 2 (TRAIL-R2) in chronic myelogenous leukemia and myelodysplastic syndrome, and analysis of mRNA Expressions of TRAIL and TRAIL-related genes in chronic myelogenous leukemia.
Liu LG; Tanaka H; Ito K; Ito T; Sultana TA; Kyo T; Kimura A
Acta Haematol; 2005; 113(2):113-23. PubMed ID: 15802890
[TBL] [Abstract][Full Text] [Related]
11. Myelodysplastic syndrome (MDS)-associated cytogenetic abnormalities in pediatric chronic myelogenous leukemia.
Kumar KR; Koduru P; Timmons C; Monaghan S; Cavalier M; Luu HS
Pediatr Blood Cancer; 2013 Nov; 60(11):E146-8. PubMed ID: 23868765
[TBL] [Abstract][Full Text] [Related]
12. A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9.
Dash AB; Williams IR; Kutok JL; Tomasson MH; Anastasiadou E; Lindahl K; Li S; Van Etten RA; Borrow J; Housman D; Druker B; Gilliland DG
Proc Natl Acad Sci U S A; 2002 May; 99(11):7622-7. PubMed ID: 12032333
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
14. Philadelphia chromosome positive myelodysplastic syndrome and acute myelogenous leukemia.
Advani AS
Leuk Res; 2004 Jun; 28(6):545-6. PubMed ID: 15120928
[No Abstract] [Full Text] [Related]
15. Chronic myelogenous leukemia: mechanisms underlying disease progression.
Shet AS; Jahagirdar BN; Verfaillie CM
Leukemia; 2002 Aug; 16(8):1402-11. PubMed ID: 12145676
[TBL] [Abstract][Full Text] [Related]
16. Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
Boultwood J; Pellagatti A; Watkins F; Campbell LJ; Esoof N; Cross NC; Eagleton H; Littlewood TJ; Fidler C; Wainscoat JS
Br J Haematol; 2004 Aug; 126(4):508-11. PubMed ID: 15287943
[TBL] [Abstract][Full Text] [Related]
17. Molecular bases of myelodysplastic syndromes: lessons from animal models.
Komeno Y; Kitaura J; Kitamura T
J Cell Physiol; 2009 Jun; 219(3):529-34. PubMed ID: 19259975
[TBL] [Abstract][Full Text] [Related]
18. [Research advance on molecular genetics of CML blast crisis].
Zhu HQ; Zhang S; Liu XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935
[TBL] [Abstract][Full Text] [Related]
19. G-CSF for chromosome analysis of myeloid leukemias and MDS.
Tsuchiya H; Higuchi S; Asou N; Yamaguchi K; Matsuda I; Yokoyama Y; Murakami T; Kaneko Y
Cancer Genet Cytogenet; 1990 Jul; 47(2):277-9. PubMed ID: 1694102
[No Abstract] [Full Text] [Related]
20. Validation and refinement of a RUNX1 mutation-associated gene expression signature in blast crisis chronic myeloid leukemia.
Lee KL; Ko TK; Saw NYL; Javed A; Hillmer AM; Chuah C; Krishnan V; Ong ST
Leukemia; 2022 Mar; 36(3):892-896. PubMed ID: 35121847
[No Abstract] [Full Text] [Related]
[Next] [New Search]